Bharat Book introduces a report "Global Markets for Treatments for Syndromes of Dementia And Movement Disorders" which Coverage of approved human antifungal therapeutics with a heavy focus on therapeutics in early development. Current and future characteristics of the global markets for treatments for syndromes of dementia and movement disorders.Comprehensive analysis of the market for genitourinary drugs on a global basis. http://www.bharatbook.com/market-research-reports/healthcare-market-research-report/2012-pharmaceuticals-research-review.html The pharmaceutical manufacturing industry in 2012 saw a slew of mergers and acquisitions, many of which were years in the planning. Outside pressures have created this “eat or be eaten” mentality, and in many respects the merger and acquisition activity simply trades some short-term problems for some problems that need to be dealt with over a longer time span. The market news has not been all bad as the overall pharmaceutical market grew to a historic trillion dollar high point. This stems from growing middle class consumption in the BRIC region (Brazil, Russia, India and China) and other regions. BCC Research has provided comprehensive coverage of pharmaceutical markets for many years, and we are now increasing our coverage of this critically important global market. This review of pharmaceutical market research conducted by BCC Research in 2012 is meant to provide a sampling of the type of quantitative market information, analysis and guidance that has been aiding business decision-making since BCC was founded in 1971. This review includes highlights from the following reports on pharmaceutical markets published BCC Research: Antifungal Drugs: Technologies and Global Markets. Global Markets for Treatments for Syndromes of Progressive Ataxia and Weakness. Global Markets for Asthma and COPD Drugs. Genitourinary Drugs: Technologies and Global Markets. Global Markets for Treatments for Syndromes of Dementia And Movement Disorders. Chapter- 1: FOREWORD - Complimentary 1 $0 Chapter- 2: GLOBAL MARKETS FOR TREATMENTS FOR SYNDROMES OF PROGRESSIVE ATAXIA AND WEAKNESS DISORDERS (REPORT PHM118A) 20 $150 INTRODUCTION EXECUTIVE SUMMARY OVERVIEW DEFINITIONS CLASSIFICATION PROGRESSIVE ATAXIA AND WEAKNESS DISORDERS DIAGNOSTIC TESTS FOR PROGRESSIVE ATAXIA AND WEAKNESS DISORDERS GLOBAL MARKETS MARKETS BY DISORDERS CURRENT SITUATION MARKET TRENDS ADDITIONAL DRIVERS FOR PROGRESSIVE ATAXIA AND WEAKNESS DISORDERS DRUG MARKET FACTORS GOVERNING THE MARKET COLLABORATIONS, MERGERS AND ACQUISITIONS Chapter- 3: ANTIFUNGAL DRUGS: TECHNOLOGIES AND GLOBAL MARKETS (REPORT PHM029D) 18 $205 INTRODUCTION SUMMARY OVERVIEW HISTORY AND CURRENT STATE OF ANTIFUNGALS TYPES OF PATHOGENIC FUNGI DEFINITION OF THE INDUSTRY INDUSTRY CONCEPTS IMPORTANCE OF THE INDUSTRY PRODUCT LIFE CYCLES DEVELOPMENT OF ANTIFUNGALS FDA-APPROVED ANTIFUNGALS FUTURE DEVELOPMENTS ACTIVE OR COMPLETED STUDIES POSTED OR UPDATED, 2009 TO 2011 INTRODUCTION TO INDUSTRY APPLICATIONS OF ANTIFUNGAL MEDICINAL THERAPEUTICS Chapter- 4: GLOBAL MARKETS FOR ASTHMA AND COPD DRUGS (REPORT PHM059B) 32 $364 INTRODUCTION SUMMARY OVERVIEW DRUG DEVELOPMENT PROCESS INDUSTRY PLAYERS ACQUISITIONS AND MERGERS COMPETITIVE FACTORS SIGNIFICANT TRENDS Chapter- 5: GENITOURINARY DRUGS: TECHNOLOGIES AND GLOBAL MARKETS (REPORT PHM115A) 16 $182 INTRODUCTION SUMMARY OVERVIEW DRUGS GOING OFF-PATENT IN FORECAST PERIOD REVENUE PROJECTION FOR GENITOURINARY DRUGS, 2011-2016 TOP 10 BEST-SELLING GENITOURINARY DRUGS, 2011 REVENUE BY GENITOURINARY DISEASE DRUG SEGMENT REVENUE FROM GENITOURINARY DRUGS BY GEOGRAPHIC AREA MARKET OVERVIEW MARKET SIZE AND FORECAST Chapter- 6: GLOBAL MARKETS FOR TREATMENTS FOR SYNDROMES OF DEMENTIA AND MOVEMENT DISORDERS (REPORT PHM117A) 25 $285 INTRODUCTION EXECUTIVE SUMMARY OVERVIEW THE BRAIN CLASSIFICATION OF NEURODEGENERATIVE DISORDERS NEURODEGENERATIVE DISORDERS DIAGNOSTIC TESTS FOR NEURODEGENERATIVE DISORDERS GLOBAL MARKETS CURRENT SITUATION MARKET TRENDS OVERALL DRIVERS OF THE MARKET FOR TREATMENTS FOR SYNDROMES OF DEMENTIA AND MOVEMENT DISORDERS OTHER FACTORS AFFECTING THE MARKET COLLABORATIONS/MERGERS AND ACQUISITIONS List of Tables Table 1 : GLOBAL MARKET FOR PROGRESSIVE ATAXIA AND WEAKNESS DISORDERS, THROUGH 2017 Table 2 : CLASSIFICATION BY PRIMARY DYSFUNCTION Table 3 : GLOBAL REVENUES OF DRUG PRODUCTS FOR THE TREATMENT OF NEURODEGENERATIVE DYSFUNCTIONS, THROUGH 2017 Table 4 : MARKET SHARE OF DRUGS USED FOR THE TREATMENT OF NEURODEGENERATIVE DISORDERS BY DYSFUNCTIONS, 2011 Table 5 : GLOBAL MARKET FORECAST FOR HUMAN ANTIFUNGAL THERAPEUTICS BY GEOGRAPHIC REGION, THROUGH 2016 Table 6 : DRUG DEVELOPMENT LIFECYCLE FOLLOWING DISCOVERY OF NEW DRUG Table 7 : CLINICAL TRIALS OF ALL NEW DRUG THERAPIES AND COMBINATIONS BY ALL DATE FIELDS, 2009–2011 Table 8 : SELECTED GLOBAL CLINICAL TRIALS OF ALL NEW DRUG THERAPIES THAT EITHER ARE COMPLETED OR ESTIMATED TO BE COMPLETED BETWEEN 2009 AND 2012 Table 9 : ACTIVE OR COMPLETED STUDIES, 2009–2011 For more information kindly visit : http://www.bharatbook.com/market-research-reports/healthcare-market-research-report/2012-pharmaceuticals-research-review.html Or Contact us at : Bharat Book Bureau Tel: +91 22 27810772 / 27810773 Toll Free No for USA/Canada : 1-866-279-8368 Email: info@bharatbook.com Website: www.bharatbook.com Follow us on twitter: https://twitter.com/researchbook Follow us on Linkedin : http://www.linkedin.com/company/bharat-book-bureau Our Blog : http://blog.bharatbook.com/
Related Articles -
healthcare market, pharmaceuticals, market forecast, market research reports,
|